Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations
Elżbieta Ciara(Children's Memorial Health Institute), Ewa Pronicka(Children's Memorial Health Institute), Edyta Szymańska(Children's Memorial Health Institute), Michał Łaźniewski(Medical University of Warsaw), Rafał Płoski(Medical University of Warsaw), Piotr Stawiński(Medical University of Warsaw), Katarzyna Iwanicka‐Pronicka(Children's Memorial Health Institute), Joanna Kosińska(Medical University of Warsaw), Hanna Mierzewska, Dorota Piekutowska‐Abramczuk(Children's Memorial Health Institute), Monika Bekiesińska‐Figatowska, Agnieszka Pollak(Institute of Physiology and Pathology of Hearing), Dariusz Rokicki(Children's Memorial Health Institute), Maciej Pronicki(Children's Memorial Health Institute), Elżbieta Jurkiewicz(Children's Memorial Health Institute), Dariusz Plewczyński(Warsaw University of Technology)
Cited by 26
Related Papers
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233
Clinical implementation of RNA sequencing for Mendelian disease diagnostics
|Genome Medicine|2022|215